Fancellu A, Sanna V, Scognamillo F, Feo CF, Vidili G, Nigri G, Porcu A. Surgical treatment of hepatocellular carcinoma in the era of COVID-19 pandemic: A comprehensive review of current recommendations. World J Clin Cases 2021; 9(15): 3517-3530 [PMID: 34046452 DOI: 10.12998/wjcc.v9.i15.3517]
Corresponding Author of This Article
Alessandro Fancellu, FACS, MD, PhD, Associate Professor, Research Scientist, Department of Medical, Surgical and Experimental Sciences, Unit of General Surgery 2 - Clinica Chirurgica, University of Sassari, V.le San Pietro 43, Sassari 07100, Italy. afancel@uniss.it
Research Domain of This Article
Surgery
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. May 26, 2021; 9(15): 3517-3530 Published online May 26, 2021. doi: 10.12998/wjcc.v9.i15.3517
Surgical treatment of hepatocellular carcinoma in the era of COVID-19 pandemic: A comprehensive review of current recommendations
Alessandro Fancellu, Valeria Sanna, Fabrizio Scognamillo, Claudio F Feo, Gianpaolo Vidili, Giuseppe Nigri, Alberto Porcu
Alessandro Fancellu, Claudio F Feo, Alberto Porcu, Department of Medical, Surgical and Experimental Sciences, Unit of General Surgery 2 - Clinica Chirurgica, University of Sassari, Sassari 07100, Italy
Valeria Sanna, Unit of Medical Oncology, AOU Sassari, Sassari 07100, Italy
Fabrizio Scognamillo, Department of Medical, Surgical and Experimental Sciences, Unit of General Surgery 1 - Patologia Chirurgica, University of Sassari, Sassari 07100, Italy
Gianpaolo Vidili, Department of Medical, Surgical and Experimental Sciences, Unit of Internal Medicine, University of Sassari, Sassari 07100, Italy
Giuseppe Nigri, Department of Medical and Surgical Sciences and Translational Medicine, Sapienza University of Rome, St. Andrea University Hospital, Rome 00189, Italy
Author contributions: Fancellu A, Sanna V and Porcu A contributed to this paper with conception and study design, manuscript writing and critical revision; Scognamillo F, Feo CF and Nigri G contributed with literature review and analysis, drafting and critical revision/editing; all authors have read and approve the final manuscript.
Conflict-of-interest statement: The authors do not have any conflicts of interest relevant to this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Alessandro Fancellu, FACS, MD, PhD, Associate Professor, Research Scientist, Department of Medical, Surgical and Experimental Sciences, Unit of General Surgery 2 - Clinica Chirurgica, University of Sassari, V.le San Pietro 43, Sassari 07100, Italy. afancel@uniss.it
Received: January 24, 2021 Peer-review started: January 24, 2021 First decision: February 22, 2021 Revised: March 2, 2021 Accepted: April 21, 2021 Article in press: April 21, 2021 Published online: May 26, 2021
Core Tip
Core Tip: Guidelines on the surgical management of hepatocellular carcinoma have been recently adapted to the prioritization of health resources to the care of patients with coronavirus disease 2019 (COVID-19). There has been a reduction in hepatic resection and liver transplant activity, which need to be restricted to very selected cases. For patients in whom surgery cannot be performed in due time, alternative or delaying strategies, mostly ablation or transarterial therapies, should be considered. The decision on surgical management should be based on risk stratification and the balance between the increased risk of COVID-19 infection, the urgency of the intervention, and the oncological effects of delayed treatment and shared with patients.
